Defibrillators promote fine-tune heart synchronization.

Press Release Summary:



CONTAK RENEWAL®, RENEWAL 3, and RENEWAL 3 RF cardiac resynchronization therapy defibrillators (CRT-D) are available with FDA-approved Left Ventricular (LV) Offset software, which lets physicians adjust delay between right and left ventricular pacing. Able to operate on ZOOM® LATITUDE(TM) programmer, LV Offset feature can be enabled during routine, in-clinic patient visit.



Original Press Release:



Boston Scientific Announces Availability of Advanced Feature in Company's Heart Failure Devices



Thousands of Heart Failure Patients Are Now Eligible for Additional Pacing Feature

NATICK, Mass., Nov. 1 -- Boston Scientific Corporation (NYSE:BSX) today announced the launch of software enabling its Left Ventricular (LV) Offset feature in the Company's CONTAK RENEWAL(R), RENEWAL 3, and RENEWAL 3 RF cardiac resynchronization therapy defibrillators (CRT-D). LV Offset allows physicians to further fine tune synchronization of the heart by allowing adjustment of the delay between right and left ventricular pacing, which helps physicians provide more tailored care for heart failure patients.

"The LV Offset capability provides yet another tool to better meet the specific treatment needs of each of my heart failure patients," said David B. DeLurgio, M.D., Director, Electrophysiology, Emory Crawford Long Hospital in Atlanta, GA.

The software will operate on the ZOOM(R) LATITUDE(TM) programmer and allow patients who have already been implanted with a CONTAK RENEWAL, RENEWAL 3 or RENEWAL 3 RF CRT-D to have the LV Offset feature activated. The LV Offset feature can be enabled by the ZOOM LATITUDE programmer during a patient's routine in-clinic visit. Boston Scientific CRM will begin providing the FDA- approved software to physicians in the coming weeks.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

All Topics